Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
MTF2	22823	broad.mit.edu	37	1	93594899	93594899	+	Missense_Mutation	SNP	C	C	T			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr1:93594899C>T	ENST00000370298.4	+	11	1343	c.1054C>T	c.(1054-1056)Cct>Tct	p.P352S	MTF2_ENST00000370303.4_Intron|MTF2_ENST00000545708.1_Missense_Mutation_p.P250S|MTF2_ENST00000540243.1_Missense_Mutation_p.P250S|MTF2_ENST00000471953.1_3'UTR	NM_001164392.1|NM_007358.3	NP_001157864.1|NP_031384.1	Q9Y483	MTF2_HUMAN	metal response element binding transcription factor 2	352		NA				nucleus	DNA binding|zinc ion binding			breast(1)|endometrium(1)|kidney(2)|large_intestine(5)|lung(6)|ovary(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	19		all_lung(203;0.00196)|Lung NSC(277;0.00902)|Melanoma(281;0.099)|Ovarian(761;0.109)|all_neural(321;0.185)|Glioma(108;0.203)		all cancers(265;0.00076)|GBM - Glioblastoma multiforme(16;0.00157)|Epithelial(280;0.0886)		TCGTGTTCCTCCTGTGCCACC	0.328	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						101	106	104	NA		NA	NA	1		NA											NA				93594899		2203	4300	6503	SO:0001583	missense			ENSG00000143033	HGNC:29535	NM_007358	Approved	uc009wdj.3	NA	A6NGQ9|A8K2Q3|B1AKT5|Q9UES9|Q9UP40	ENST00000370298.4	37	CCDS742.1	.	.	.	.	.	.	.	.	.	.	C	27.1	4.802520	0.90538	.	.	ENSG00000143033	ENST00000545708;ENST00000540243;ENST00000370298;ENST00000537953	T;T;T	0.46063	0.88;0.88;1.23	5.55	5.55	0.83447	.	0.000000	0.85682	D	0.000000	T	0.64886	0.2639	M	0.82193	2.58	0.80722	D	1	D;D	0.89917	0.998;1.0	D;D	0.97110	0.978;1.0	T	0.66941	-0.5796	10	0.56958	D	0.05	-6.0652	19.8683	0.96840	0.0:1.0:0.0:0.0	.	352;250	Q9Y483;B4DZG1	MTF2_HUMAN;.	S	250;250;352;250	ENSP00000444962:P250S;ENSP00000443295:P250S;ENSP00000359321:P352S	ENSP00000359321:P352S	P	+	1	0	MTF2	93367487	1.000000	0.71417	1.000000	0.80357	0.998000	0.95712	6.907000	0.75724	2.753000	0.94483	0.655000	0.94253	CCT	MTF2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000028075.3	13.107608	KEEP		+	28.124589	0.121495	13	94	---	---	---	---	1	0.9729946	2	33	0	127	17	108	0	127	2	0	0	0	0	0	0	17	108	0	127	2	TP
PTGFRN	5738	broad.mit.edu	37	1	117491914	117491914	+	Silent	SNP	C	C	T	rs140719535		STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr1:117491914C>T	ENST00000393203.2	+	4	1080	c.933C>T	c.(931-933)ccC>ccT	p.P311P		NM_020440.2	NP_065173.2	Q9P2B2	FPRP_HUMAN	prostaglandin F2 receptor inhibitor	311	Ig-like C2-type 3.	NA				endoplasmic reticulum membrane|Golgi apparatus|integral to membrane	protein binding			NS(1)|breast(1)|endometrium(4)|large_intestine(10)|liver(1)|lung(22)|ovary(1)|prostate(4)|stomach(1)|upper_aerodigestive_tract(1)	46	Lung SC(450;0.225)	all_cancers(81;0.00104)|all_lung(203;8.97e-05)|all_epithelial(167;0.000139)|Lung NSC(69;0.000446)		Lung(183;0.0704)|LUSC - Lung squamous cell carcinoma(189;0.227)|Colorectal(144;0.248)		ACGTCCGGCCCGAGGTGACGT	0.607	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA	C		0,4406		0,0,2203	116	99	105	NA	933	-6.1	0	1	dbSNP_134	105	1,8599	1.2+/-3.3	0,1,4299	no	coding-synonymous	PTGFRN	NM_020440.2		0,1,6502	TT,TC,CC	NA	0.0116,0.0,0.0077		311/880	117491914	1,13005	2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000134247	HGNC:9601	NM_020440	Approved	uc001egv.1	NA	Q5VVU9|Q8N2K6	ENST00000393203.2	37	CCDS890.1																																																																																			PTGFRN-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000033271.1	4.253624	KEEP		+	16.021398	0.105263	8	68	---	---	---	---	1	0.9996546	20	167	0	112	10	120	0	112	2	0	0	0	0	0	0	10	120	0	112	2	TP
PIAS3	10401	broad.mit.edu	37	1	145584516	145584516	+	Silent	SNP	C	C	T			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr1:145584516C>T	ENST00000393045.2	+	12	1573	c.1483C>T	c.(1483-1485)Cta>Tta	p.L495L	PIAS3_ENST00000369298.1_Silent_p.L460L	NM_006099.3	NP_006090.2	Q9Y6X2	PIAS3_HUMAN	protein inhibitor of activated STAT, 3	495		NA			positive regulation of protein sumoylation|protein sumoylation|regulation of transcription, DNA-dependent|transcription, DNA-dependent	nuclear speck	enzyme binding|nucleic acid binding|protein C-terminus binding|zinc ion binding			cervix(1)|endometrium(4)|kidney(1)|large_intestine(5)|lung(14)|ovary(1)|prostate(2)	28	all_hematologic(18;0.0187)|Acute lymphoblastic leukemia(18;0.0786)					ATCCTCGGTGCTAAGGAGCCC	0.607	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						105	105	105	NA		NA	NA	1		NA											NA				145584516		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000131788	HGNC:16861	NM_006099	Approved	uc001eoc.1	NA	Q9UFI3	ENST00000393045.2	37	CCDS920.2																																																																																			PIAS3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000038533.4	-6.228011	KEEP		+	17.094704	0.072581	9	115	---	---	---	---	1	0.996437	19	142	0	151	9	139	0	151	2	0	0	0	0	0	0	9	139	0	151	2	TP
OTUD7B	56957	broad.mit.edu	37	1	149921651	149921651	+	Missense_Mutation	SNP	T	T	C			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr1:149921651T>C	ENST00000369135.3	-	9	1298	c.1004A>G	c.(1003-1005)tAt>tGt	p.Y335C		NM_020205.2	NP_064590.2	Q6GQQ9	OTU7B_HUMAN	OTU domain containing 7B	335	Catalytic.|OTU.|TRAF-binding.	NA			negative regulation of I-kappaB kinase/NF-kappaB cascade	cytoplasm|microtubule cytoskeleton|nucleus	cysteine-type peptidase activity|DNA binding|protein binding|zinc ion binding			breast(1)|endometrium(6)|kidney(2)|large_intestine(5)|lung(18)|ovary(1)|prostate(2)|skin(1)|upper_aerodigestive_tract(2)|urinary_tract(1)	39	Breast(34;0.0009)|Ovarian(49;0.0265)|all_hematologic(923;0.0597)|Hepatocellular(266;0.161)|Colorectal(459;0.171)		LUSC - Lung squamous cell carcinoma(543;0.171)|STAD - Stomach adenocarcinoma(528;0.247)			CAAAGGCAGATAGATTCCTCC	0.532	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						48	51	50	NA		NA	NA	1		NA											NA				149921651		1973	4167	6140	SO:0001583	missense			ENSG00000163113	HGNC:16683	NM_020205	Approved	uc001etn.3	NA	D3DUZ8|Q5SZ60|Q8WWA7|Q9NQ53|Q9UFF4	ENST00000369135.3	37	CCDS41389.1	.	.	.	.	.	.	.	.	.	.	T	21.3	4.133146	0.77662	.	.	ENSG00000163113	ENST00000369135;ENST00000543330;ENST00000417191	T;T	0.35236	1.32;1.32	5.05	5.05	0.67936	Ovarian tumour, otubain (2);	0.000000	0.85682	D	0.000000	T	0.57227	0.2039	M	0.87381	2.88	0.80722	D	1	D	0.89917	1.0	D	0.87578	0.998	T	0.64993	-0.6276	9	.	.	.	-13.428	14.1256	0.65217	0.0:0.0:0.0:1.0	.	335	Q6GQQ9	OTU7B_HUMAN	C	335	ENSP00000358131:Y335C;ENSP00000408231:Y335C	.	Y	-	2	0	OTUD7B	148188275	1.000000	0.71417	1.000000	0.80357	0.995000	0.86356	7.525000	0.81892	2.127000	0.65507	0.482000	0.46254	TAT	OTUD7B-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000034146.2	15.174591	KEEP		-	20.898201	0.156863	8	43	---	---	---	---	1	0.9996339	5	79	0	42	9	44	0	42	2	0	0	0	0	0	0	9	44	0	42	2	TP
PMS1	0	broad.mit.edu	37	2	190660534	190660534	+	Missense_Mutation	SNP	G	G	A			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr2:190660534G>A	ENST00000441310.2	+	3	405	c.172G>A	c.(172-174)Ggg>Agg	p.G58R	PMS1_ENST00000447232.2_Missense_Mutation_p.G58R|PMS1_ENST00000432292.3_Intron|PMS1_ENST00000421722.1_3'UTR|PMS1_ENST00000418224.3_5'UTR|PMS1_ENST00000409823.3_Missense_Mutation_p.G58R|PMS1_ENST00000409985.1_Missense_Mutation_p.G58R|PMS1_ENST00000374826.4_Missense_Mutation_p.G58R	NM_000534.4	NP_000525.1	P54277	PMS1_HUMAN	PMS1 postmeiotic segregation increased 1 (S. cerevisiae)	58		NA			mismatch repair|reciprocal meiotic recombination	MutLalpha complex	ATP binding|ATPase activity|mismatched DNA binding			breast(3)|central_nervous_system(1)|endometrium(2)|haematopoietic_and_lymphoid_tissue(2)|kidney(3)|large_intestine(5)|lung(16)|ovary(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	36			OV - Ovarian serous cystadenocarcinoma(117;0.0013)|Epithelial(96;0.0263)|all cancers(119;0.0751)			GCGAGATAACGGGGAGGGTAT	0.328	NA	NA	"""Mis, N"""			"""colorectal, endometrial, ovarian"""	NA	Direct reversal of damage;Mismatch excision repair (MMR)						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Rec		Hereditary non-polyposis colorectal cancer	2	2q31-q33	5378	PMS1 postmeiotic segregation increased 1 (S. cerevisiae)	NA	E	0			NA	NA	NA	NA	NA						82	82	82	NA		NA	NA	2		NA											NA				190660534		2203	4300	6503	SO:0001583	missense			ENSG00000064933	HGNC:9121		Approved	uc002urh.4	NA	D3DPI1	ENST00000441310.2	37	CCDS2302.1	.	.	.	.	.	.	.	.	.	.	G	34	5.319768	0.95682	.	.	ENSG00000064933	ENST00000441310;ENST00000409985;ENST00000409823;ENST00000374826;ENST00000424766;ENST00000447232;ENST00000420421	D;D;D;D;D;D;D	0.99829	-5.18;-5.18;-5.18;-5.18;-5.18;-5.18;-7.0	5.78	5.78	0.91487	DNA mismatch repair protein, N-terminal (1);ATPase-like, ATP-binding domain (4);	0.090324	0.85682	D	0.000000	D	0.99919	0.9962	H	0.99325	4.515	0.80722	D	1	D;D;D;D;D;D;D	0.89917	1.0;1.0;1.0;1.0;1.0;1.0;1.0	D;D;D;D;D;D;D	0.97110	1.0;1.0;1.0;1.0;1.0;1.0;1.0	D	0.96159	0.9114	10	0.87932	D	0	-22.3482	20.0159	0.97477	0.0:0.0:1.0:0.0	.	58;58;58;58;58;58;58	B4DMF4;E9PC40;Q5FBZ4;Q5FBZ9;Q5FBZ3;Q5FBZ8;P54277	.;.;.;.;.;.;PMS1_HUMAN	R	58	ENSP00000406490:G58R;ENSP00000386623:G58R;ENSP00000387125:G58R;ENSP00000363959:G58R;ENSP00000410082:G58R;ENSP00000401064:G58R;ENSP00000391136:G58R	ENSP00000343888:G58R	G	+	1	0	PMS1	190368779	1.000000	0.71417	1.000000	0.80357	0.981000	0.71138	9.814000	0.99346	2.743000	0.94032	0.637000	0.83480	GGG	PMS1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000255918.2	24.006212	KEEP		+	32.411288	0.170732	14	68	---	---	---	---	1	0.9791663	15	20	0	70	18	90	0	70	2	0	0	0	0	0	0	18	90	0	70	2	TP
PLS1	5357	broad.mit.edu	37	3	142416830	142416830	+	Missense_Mutation	SNP	A	A	G			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr3:142416830A>G	ENST00000337777.3	+	12	1505	c.1292A>G	c.(1291-1293)tAt>tGt	p.Y431C	PLS1_ENST00000457734.2_Missense_Mutation_p.Y431C|PLS1_ENST00000497002.1_Missense_Mutation_p.Y431C	NM_002670.2	NP_002661.2	Q14651	PLSI_HUMAN	plastin 1	431	Actin-binding 2.|CH 3.	NA				cytoplasm	actin filament binding|calcium ion binding|structural constituent of cytoskeleton			NS(1)|breast(1)|cervix(1)|endometrium(4)|kidney(1)|large_intestine(6)|lung(9)|ovary(1)|pancreas(1)|skin(1)|stomach(1)	27						TTTCAGCTCTATGAGATGATC	0.433	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						130	115	120	NA		NA	NA	3		NA											NA				142416830		2203	4300	6503	SO:0001583	missense			ENSG00000120756	HGNC:9090	NM_002670	Approved	uc003euz.3	NA	A8K2Q1|D3DNG3|Q8NEG6	ENST00000337777.3	37	CCDS3125.1	.	.	.	.	.	.	.	.	.	.	A	19.23	3.787200	0.70337	.	.	ENSG00000120756	ENST00000457734;ENST00000337777;ENST00000497002	D;D;D	0.95588	-3.75;-3.75;-3.75	5.71	5.71	0.89125	Calponin homology domain (5);	0.297823	0.38548	N	0.001655	D	0.97062	0.9040	M	0.71296	2.17	0.80722	D	1	D	0.67145	0.996	P	0.62649	0.905	D	0.97564	1.0100	10	0.72032	D	0.01	-16.2775	15.9812	0.80111	1.0:0.0:0.0:0.0	.	431	Q14651	PLSI_HUMAN	C	431	ENSP00000387890:Y431C;ENSP00000336831:Y431C;ENSP00000418700:Y431C	ENSP00000336831:Y431C	Y	+	2	0	PLS1	143899520	1.000000	0.71417	1.000000	0.80357	0.996000	0.88848	6.028000	0.70889	2.178000	0.69098	0.533000	0.62120	TAT	PLS1-002	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000354435.1	15.035482	KEEP		+	30.921131	0.11215	12	95	---	---	---	---	1	0.9999999	86	282	0	101	13	117	0	101	2	0	0	0	0	0	0	13	117	0	101	2	TP
MUC4	4585	broad.mit.edu	37	3	195509388	195509388	+	Silent	SNP	G	G	A	rs71291868		STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr3:195509388G>A	ENST00000463781.3	-	2	9522	c.9063C>T	c.(9061-9063)caC>caT	p.H3021H	MUC4_ENST00000475231.1_Silent_p.H3021H|MUC4_ENST00000349607.4_Intron|MUC4_ENST00000346145.4_Intron	NM_018406.6	NP_060876.5	Q99102	MUC4_HUMAN	mucin 4, cell surface associated	769		NA			cell-matrix adhesion	integral to plasma membrane|proteinaceous extracellular matrix	ErbB-2 class receptor binding|extracellular matrix constituent, lubricant activity			NS(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(3)|kidney(1)|large_intestine(5)|lung(23)|ovary(3)|prostate(8)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(1)	51	all_cancers(143;1.11e-08)|Ovarian(172;0.0634)|Breast(254;0.206)	Lung NSC(153;0.191)	Epithelial(36;3.72e-24)|all cancers(36;6.22e-22)|OV - Ovarian serous cystadenocarcinoma(49;1.1e-18)|Lung(62;4.65e-05)|LUSC - Lung squamous cell carcinoma(58;5.31e-05)	GBM - Glioblastoma multiforme(46;2.37e-05)		GAGGGGTGGCGTGACCTGTGG	0.592	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						26	19	21	NA		NA	NA	3		NA											NA				195509388		666	1575	2241	SO:0001819	synonymous_variant			ENSG00000145113	HGNC:7514	NM_018406	Approved	uc021xjp.1	NA	O95938|Q9GZM2|Q9GZV6|Q9H481|Q9H482|Q9H483|Q9H484|Q9H485|Q9H486|Q9H487|Q9H4D6|Q9H4D8|Q9NPJ0|Q9NY09|Q9NY75|Q9NY76|Q9NY77|Q9NY78|Q9NY79|Q9NY80|Q9NY81	ENST00000463781.3	37	CCDS54700.1																																																																																			MUC4-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000324081.6	-5.973383	KEEP		-	6.726684	0.0625	4	60	---	---	---	---	1	0.7726114	4	50	0	52	4	75	0	52	2	0	0	0	0	0	0	4	75	0	52	2	TP
MUC4	4585	broad.mit.edu	37	3	195509402	195509402	+	Missense_Mutation	SNP	T	T	C	rs71291868|rs74772699		STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr3:195509402T>C	ENST00000463781.3	-	2	9508	c.9049A>G	c.(9049-9051)Ata>Gta	p.I3017V	MUC4_ENST00000475231.1_Missense_Mutation_p.I3017V|MUC4_ENST00000349607.4_Intron|MUC4_ENST00000346145.4_Intron	NM_018406.6	NP_060876.5	Q99102	MUC4_HUMAN	mucin 4, cell surface associated	765		NA			cell-matrix adhesion	integral to plasma membrane|proteinaceous extracellular matrix	ErbB-2 class receptor binding|extracellular matrix constituent, lubricant activity			NS(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(3)|kidney(1)|large_intestine(5)|lung(23)|ovary(3)|prostate(8)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(1)	51	all_cancers(143;1.11e-08)|Ovarian(172;0.0634)|Breast(254;0.206)	Lung NSC(153;0.191)	Epithelial(36;3.72e-24)|all cancers(36;6.22e-22)|OV - Ovarian serous cystadenocarcinoma(49;1.1e-18)|Lung(62;4.65e-05)|LUSC - Lung squamous cell carcinoma(58;5.31e-05)	GBM - Glioblastoma multiforme(46;2.37e-05)		CCTGTGGATATTGAGGAAGTG	0.587	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						25	19	21	NA		NA	NA	3		NA											NA				195509402		664	1572	2236	SO:0001583	missense			ENSG00000145113	HGNC:7514	NM_018406	Approved	uc021xjp.1	NA	O95938|Q9GZM2|Q9GZV6|Q9H481|Q9H482|Q9H483|Q9H484|Q9H485|Q9H486|Q9H487|Q9H4D6|Q9H4D8|Q9NPJ0|Q9NY09|Q9NY75|Q9NY76|Q9NY77|Q9NY78|Q9NY79|Q9NY80|Q9NY81	ENST00000463781.3	37	CCDS54700.1	.	.	.	.	.	.	.	.	.	.	N	0.936	-0.711230	0.03230	.	.	ENSG00000145113	ENST00000463781;ENST00000475231	T;T	0.29917	1.55;1.55	.	.	.	.	.	.	.	.	T	0.14960	0.0361	N	0.14661	0.345	0.09310	N	0.999999	B	0.15141	0.012	B	0.04013	0.001	T	0.29822	-0.9999	6	.	.	.	.	.	.	.	.	2889	E7ESK3	.	V	3017	ENSP00000417498:I3017V;ENSP00000420243:I3017V	.	I	-	1	0	MUC4	196994181	0.002000	0.14202	0.016000	0.15963	0.000000	0.00434	-2.362000	0.01082	0.402000	0.25451	0.000000	0.15137	ATA	MUC4-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000324081.6	-3.035933	KEEP		-	9.442207	0.063492	4	59	---	---	---	---	1	0.7631709	5	47	0	63	4	74	0	63	2	0	0	0	0	0	0	4	74	0	63	2	TP
TIGD2	166815	broad.mit.edu	37	4	90034294	90034294	+	Missense_Mutation	SNP	A	A	G			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr4:90034294A>G	ENST00000317005.2	+	1	327	c.169A>G	c.(169-171)Aac>Gac	p.N57D	RP11-84C13.1_ENST00000603357.1_lincRNA|FAM13A_ENST00000502459.1_5'Flank	NM_145715.2	NP_663761.1	Q4W5G0	TIGD2_HUMAN	tigger transposable element derived 2	57		NA			regulation of transcription, DNA-dependent	chromosome, centromeric region|nucleus	DNA binding			breast(1)|cervix(1)|endometrium(1)|large_intestine(1)|lung(3)|ovary(1)|prostate(1)|skin(1)|upper_aerodigestive_tract(3)|urinary_tract(1)	14		Hepatocellular(203;0.114)		OV - Ovarian serous cystadenocarcinoma(123;3.86e-05)		AAACTATGCAAACAGTTCAGA	0.373	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						97	94	95	NA		NA	NA	4		NA											NA				90034294		2203	4300	6503	SO:0001583	missense			ENSG00000180346	HGNC:18333	NM_145715	Approved	uc003hsk.3	NA		ENST00000317005.2	37	CCDS3633.1	.	.	.	.	.	.	.	.	.	.	a	12.27	1.887321	0.33348	.	.	ENSG00000180346	ENST00000317005	T	0.41400	1.0	3.56	3.56	0.40772	Homeodomain-related (1);Homeodomain-like (1);	0.149000	0.30483	U	0.009529	T	0.18882	0.0453	N	0.08118	0	0.23930	N	0.99643	P	0.35328	0.495	B	0.30716	0.119	T	0.13282	-1.0515	10	0.17369	T	0.5	.	10.1259	0.42649	1.0:0.0:0.0:0.0	.	57	Q4W5G0	TIGD2_HUMAN	D	57	ENSP00000317170:N57D	ENSP00000317170:N57D	N	+	1	0	TIGD2	90253317	0.895000	0.30542	0.986000	0.45419	0.993000	0.82548	1.766000	0.38491	1.501000	0.48654	0.373000	0.22412	AAC	TIGD2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000253545.2	47.84579	KEEP		+	57.035164	0.192308	20	84	---	---	---	---	1	0.9982208	18	22	0	129	25	90	0	129	2	0	0	0	0	0	0	25	90	0	129	2	TP
UFSP2	55325	broad.mit.edu	37	4	186329110	186329110	+	Silent	SNP	C	C	T			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr4:186329110C>T	ENST00000264689.6	-	9	1217	c.1101G>A	c.(1099-1101)acG>acA	p.T367T		NM_018359.3	NP_060829.2	Q9NUQ7	UFSP2_HUMAN	UFM1-specific peptidase 2	367		NA				endoplasmic reticulum|nucleus	small conjugating protein-specific protease activity			endometrium(3)|kidney(1)|large_intestine(3)|lung(3)|upper_aerodigestive_tract(1)|urinary_tract(1)	12		all_lung(41;1.3e-11)|Lung NSC(41;2.25e-11)|Melanoma(20;0.00109)|Colorectal(36;0.0215)|Renal(120;0.0246)|Hepatocellular(41;0.0268)|Prostate(90;0.0283)|all_hematologic(60;0.0749)		all cancers(43;3.4e-25)|Epithelial(43;2.23e-22)|OV - Ovarian serous cystadenocarcinoma(60;1.54e-11)|BRCA - Breast invasive adenocarcinoma(30;8.1e-05)|GBM - Glioblastoma multiforme(59;0.000148)|STAD - Stomach adenocarcinoma(60;0.000782)|LUSC - Lung squamous cell carcinoma(40;0.00939)|COAD - Colon adenocarcinoma(29;0.0108)|READ - Rectum adenocarcinoma(43;0.166)		GGATTTTTGACGTTATACCGA	0.373	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						98	87	91	NA		NA	NA	4		NA											NA				186329110		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000109775	HGNC:25640	NM_018359	Approved	uc003ixo.2	NA	Q6IA77|Q96FS3	ENST00000264689.6	37	CCDS3842.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	c|c	13.95|13.95	2.391267|2.391267	0.42410|0.42410	.|.	.|.	ENSG00000109775|ENSG00000109775	ENST00000509180|ENST00000511485	.|.	.|.	.|.	5.87|5.87	-1.41|-1.41	0.08941|0.08941	.|.	.|.	.|.	.|.	.|.	T|T	0.42765|0.42765	0.1217|0.1217	.|.	.|.	.|.	0.80722|0.80722	D|D	1|1	.|.	.|.	.|.	.|.	.|.	.|.	T|T	0.30475|0.30475	-0.9977|-0.9977	4|4	.|.	.|.	.|.	-5.3052|-5.3052	3.4035|3.4035	0.07332|0.07332	0.3078:0.3647:0.0602:0.2673|0.3078:0.3647:0.0602:0.2673	.|.	.|.	.|.	.|.	H|I	96|266	.|.	.|.	R|V	-|-	2|1	0|0	UFSP2|UFSP2	186566104|186566104	0.941000|0.941000	0.31946|0.31946	0.994000|0.994000	0.49952|0.49952	0.834000|0.834000	0.47266|0.47266	0.132000|0.132000	0.15891|0.15891	-0.041000|-0.041000	0.13558|0.13558	-0.259000|-0.259000	0.10710|0.10710	CGT|GTC	UFSP2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000360589.2	-0.334824	KEEP		-	7.353067	0.088889	4	41	---	---	---	---	1	0.9996923	33	186	0	35	5	49	0	35	2	0	0	0	0	0	0	5	49	0	35	2	TP
ETF1	2107	broad.mit.edu	37	5	137844018	137844018	+	Silent	SNP	T	T	C			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr5:137844018T>C	ENST00000499810.2	-	11	1639	c.1191A>G	c.(1189-1191)gaA>gaG	p.E397E	ETF1_ENST00000503014.1_Silent_p.E416E|ETF1_ENST00000360541.5_Silent_p.E430E			P62495	ERF1_HUMAN	eukaryotic translation termination factor 1	430		NA			nuclear-transcribed mRNA catabolic process, nonsense-mediated decay|protein methylation|regulation of translational termination	cytoplasm	protein binding|ribosome binding|translation release factor activity, codon specific			breast(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(2)|kidney(1)|large_intestine(6)|lung(3)|ovary(2)|prostate(1)|urinary_tract(1)	18			KIRC - Kidney renal clear cell carcinoma(527;0.00185)|Kidney(363;0.00325)			GGTCAAAAAATTCATCGTCTC	0.488	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						62	51	55	NA		NA	NA	5		NA											NA				137844018		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000120705	HGNC:3477	NM_004730	Approved	uc003ldc.5	NA	B2R6B4|D3DQC1|P46055|Q5M7Z7	ENST00000499810.2	37																																																																																				ETF1-002	PUTATIVE	basic|exp_conf	protein_coding	NA	protein_coding	OTTHUMT00000373726.1	1.366534	KEEP		-	9.569767	0.085106	4	43	---	---	---	---	1	0.9999927	112	357	0	36	5	50	0	36	2	0	0	0	0	0	0	5	50	0	36	2	TP
CDYL	9425	broad.mit.edu	37	6	4892004	4892004	+	Missense_Mutation	SNP	C	C	T			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr6:4892004C>T	ENST00000328908.5	+	4	375	c.244C>T	c.(244-246)Cgg>Tgg	p.R82W	CDYL_ENST00000472453.1_Intron|CDYL_ENST00000343762.5_5'UTR|CDYL_ENST00000397588.3_Missense_Mutation_p.R28W|CDYL_ENST00000449732.2_5'UTR			Q9Y232	CDYL1_HUMAN	chromodomain protein, Y-like	82	Chromo.	NA			regulation of transcription, DNA-dependent|spermatogenesis|transcription, DNA-dependent	nucleus	histone acetyltransferase activity			breast(2)|kidney(2)|large_intestine(9)|lung(13)|skin(1)|stomach(2)|urinary_tract(1)	30	Ovarian(93;0.11)	all_hematologic(90;0.0901)|Lung NSC(90;0.244)		OV - Ovarian serous cystadenocarcinoma(45;0.182)		GTATTTGGTTCGGTGGAAAGG	0.408	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						73	69	70	NA		NA	NA	6		NA											NA				4892004		2203	4300	6503	SO:0001583	missense			ENSG00000153046	HGNC:1811	NM_004824	Approved	uc003mwj.3	NA	A8K6D6|B4DLG4|Q0VDG7|Q32NC5|Q5VX99|Q6P7T5|Q9BWZ2|Q9Y424	ENST00000328908.5	37		.	.	.	.	.	.	.	.	.	.	C	22.7	4.329384	0.81690	.	.	ENSG00000153046	ENST00000328908;ENST00000397588	T;T	0.72942	0.82;-0.7	5.64	4.74	0.60224	Chromo domain (1);Chromo domain-like (1);Chromo domain/shadow (2);Chromo domain, conserved site (1);	0.000000	0.85682	D	0.000000	D	0.84042	0.5385	M	0.88310	2.945	0.80722	D	1	D;D	0.89917	1.0;1.0	D;D	0.91635	0.992;0.999	D	0.86604	0.1868	10	0.87932	D	0	.	15.0594	0.71939	0.1422:0.8578:0.0:0.0	.	28;82	Q9Y232-2;Q9Y232	.;CDYL1_HUMAN	W	82;28	ENSP00000330512:R82W;ENSP00000380718:R28W	ENSP00000330512:R82W	R	+	1	2	CDYL	4837003	1.000000	0.71417	0.992000	0.48379	0.991000	0.79684	3.132000	0.50523	2.651000	0.90000	0.650000	0.86243	CGG	CDYL-001	KNOWN	basic	protein_coding	NA	protein_coding	OTTHUMT00000039736.1	74.886219	KEEP		+	76.698553	0.348315	31	58	---	---	---	---	1	1	66	37	0	60	36	70	0	60	2	0	0	0	0	0	0	36	70	0	60	2	TP
TRERF1	55809	broad.mit.edu	37	6	42236873	42236873	+	Silent	SNP	G	G	A			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr6:42236873G>A	ENST00000541110.1	-	5	1024	c.456C>T	c.(454-456)aaC>aaT	p.N152N	TRERF1_ENST00000372917.4_Silent_p.N152N|TRERF1_ENST00000354325.2_Silent_p.N152N|TRERF1_ENST00000372922.4_Silent_p.N152N|TRERF1_ENST00000340840.2_Silent_p.N152N			Q96PN7	TREF1_HUMAN	transcriptional regulating factor 1	152		NA			cholesterol catabolic process|homeostatic process|multicellular organismal development|positive regulation of transcription, DNA-dependent|regulation of hormone biosynthetic process|steroid biosynthetic process	nucleus	DNA bending activity|ligand-dependent nuclear receptor transcription coactivator activity|RNA polymerase II transcription cofactor activity|sequence-specific DNA binding transcription factor activity|transcription factor binding|zinc ion binding			breast(1)|central_nervous_system(2)|endometrium(7)|kidney(1)|large_intestine(12)|lung(13)|ovary(3)|pancreas(1)|skin(3)|urinary_tract(2)	45	Colorectal(47;0.196)		Colorectal(64;0.00062)|COAD - Colon adenocarcinoma(64;0.00152)			GCAGGTTTTGGTTGGCAAACA	0.557	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA	G		1,4405	2.1+/-5.4	0,1,2202	174	180	178	NA	456	4.5	1	6		178	0,8600		0,0,4300	no	coding-synonymous	TRERF1	NM_033502.2		0,1,6502	AA,AG,GG	NA	0.0,0.0227,0.0077		152/1201	42236873	1,13005	2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000124496	HGNC:18273	NM_033502	Approved	uc003osd.2	NA	Q05GC6|Q7Z6T2|Q7Z6T3|Q9NQ72|Q9NQ73|Q9NUN9	ENST00000541110.1	37																																																																																				TRERF1-202	KNOWN	basic	protein_coding	NA	protein_coding		-38.665395	KEEP		-	26.29387	0.049669	15	287	---	---	---	---	1	0.6982622	11	41	0	333	17	356	0	333	2	0	0	0	0	0	0	17	356	0	333	2	TP
TPBG	7162	broad.mit.edu	37	6	83075655	83075655	+	Missense_Mutation	SNP	C	C	T			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr6:83075655C>T	ENST00000369750.3	+	2	1594	c.977C>T	c.(976-978)cCg>cTg	p.P326L	TPBG_ENST00000535040.1_Missense_Mutation_p.P326L|TPBG_ENST00000543496.1_Missense_Mutation_p.P326L			Q13641	TPBG_HUMAN	trophoblast glycoprotein	326	LRRCT.	NA			cell adhesion	integral to plasma membrane				central_nervous_system(1)|endometrium(1)|large_intestine(2)|lung(6)|ovary(2)|prostate(1)|skin(1)|stomach(1)	15		all_cancers(76;0.000805)|Acute lymphoblastic leukemia(125;3.85e-06)|all_hematologic(105;0.0017)|all_epithelial(107;0.0897)		BRCA - Breast invasive adenocarcinoma(397;0.107)		TGTGCATATCCGGAAAAAATG	0.537	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						118	107	111	NA		NA	NA	6		NA											NA				83075655		2203	4300	6503	SO:0001583	missense			ENSG00000146242	HGNC:12004		Approved	uc003pjo.3	NA		ENST00000369750.3	37	CCDS4995.1	.	.	.	.	.	.	.	.	.	.	C	13.47	2.247440	0.39697	.	.	ENSG00000146242	ENST00000535040;ENST00000369750;ENST00000543496	D;D;D	0.93133	-3.17;-3.17;-3.17	5.74	4.88	0.63580	Cysteine-rich flanking region, C-terminal (2);	0.000000	0.85682	D	0.000000	D	0.95781	0.8627	M	0.78049	2.395	0.80722	D	1	D	0.89917	1.0	D	0.85130	0.997	D	0.96481	0.9356	10	0.87932	D	0	-16.5253	14.7278	0.69357	0.0:0.9306:0.0:0.0694	.	326	Q13641	TPBG_HUMAN	L	326	ENSP00000441219:P326L;ENSP00000358765:P326L;ENSP00000440049:P326L	ENSP00000358765:P326L	P	+	2	0	TPBG	83132374	1.000000	0.71417	0.970000	0.41538	0.029000	0.11900	7.487000	0.81328	1.442000	0.47568	-0.142000	0.14014	CCG	TPBG-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000041340.1	-6.995453	KEEP		+	16.833659	0.071429	9	117	---	---	---	---	1	0.9601117	15	70	0	103	9	132	0	103	2	0	0	0	0	0	0	9	132	0	103	2	TP
BUD31	8896	broad.mit.edu	37	7	99015162	99015162	+	Missense_Mutation	SNP	G	G	C			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr7:99015162G>C	ENST00000403633.2	+	5	857	c.328G>C	c.(328-330)Gac>Cac	p.D110H	BUD31_ENST00000431419.1_Missense_Mutation_p.D81H|BUD31_ENST00000456893.1_Missense_Mutation_p.D69H|BUD31_ENST00000222969.5_Missense_Mutation_p.D110H|PTCD1_ENST00000292478.4_3'UTR			P41223	BUD31_HUMAN	BUD31 homolog (S. cerevisiae)	110		NA			regulation of transcription from RNA polymerase II promoter	nucleus	sequence-specific DNA binding transcription factor activity			autonomic_ganglia(1)|haematopoietic_and_lymphoid_tissue(1)|lung(1)|ovary(1)	4	all_cancers(62;1.76e-08)|all_epithelial(64;1.63e-09)|Lung NSC(181;0.0053)|all_lung(186;0.00895)|Esophageal squamous(72;0.0166)		STAD - Stomach adenocarcinoma(171;0.215)			TCAGACACGGGACACCAACTT	0.453	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						94	84	87	NA		NA	NA	7		NA											NA				99015162		2203	4300	6503	SO:0001583	missense			ENSG00000106245	HGNC:29629	NM_003910	Approved	uc003uqg.4	NA	A4D274|D6W5S6|Q6IB53|Q9UDV1	ENST00000403633.2	37	CCDS5663.1	.	.	.	.	.	.	.	.	.	.	G	22.4	4.289098	0.80914	.	.	ENSG00000106245	ENST00000403633;ENST00000222969;ENST00000456893;ENST00000431419	.	.	.	5.48	4.6	0.57074	BUD31/G10-related, conserved site (1);	0.000000	0.85682	D	0.000000	D	0.83977	0.5371	M	0.90252	3.1	0.80722	D	1	D;D	0.76494	0.999;0.997	D;D	0.73708	0.979;0.981	D	0.87253	0.2274	9	0.72032	D	0.01	-39.2451	13.9903	0.64362	0.0727:0.0:0.9273:0.0	.	110;110	B7Z4S9;P41223	.;BUD31_HUMAN	H	110;110;69;81	.	ENSP00000222969:D110H	D	+	1	0	BUD31	98853098	1.000000	0.71417	1.000000	0.80357	0.809000	0.45718	9.441000	0.97557	1.314000	0.45095	0.655000	0.94253	GAC	BUD31-002	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000336275.1	5.382261	KEEP		+	17.327504	0.09589	7	66	---	---	---	---	1	1	119	1285	0	79	7	77	0	79	2	0	0	0	0	0	0	7	77	0	79	2	TP
RBM28	55131	broad.mit.edu	37	7	127978360	127978360	+	Missense_Mutation	SNP	T	T	C			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr7:127978360T>C	ENST00000223073.1	-	5	599	c.485A>G	c.(484-486)aAa>aGa	p.K162R	RBM28_ENST00000415472.2_Intron	NM_018077.2	NP_060547.2	Q9NW13	RBM28_HUMAN	RNA binding motif protein 28	162	RRM 2.	NA			mRNA processing|RNA splicing	Golgi apparatus|nucleolus|spliceosomal complex	nucleotide binding|RNA binding			breast(1)|kidney(7)|large_intestine(3)|lung(8)|ovary(2)	21						TAGGAGGTTTTTGAACTGAAC	0.418	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						120	110	113	NA		NA	NA	7		NA											NA				127978360		2203	4300	6503	SO:0001583	missense			ENSG00000106344	HGNC:21863	NM_018077	Approved	uc003vmp.2	NA	A4D100|Q53H65|Q96CV3	ENST00000223073.1	37	CCDS5801.1	.	.	.	.	.	.	.	.	.	.	T	13.65	2.301218	0.40694	.	.	ENSG00000106344	ENST00000223073;ENST00000459726	D;T	0.85629	-2.01;2.28	5.73	5.73	0.89815	Nucleotide-binding, alpha-beta plait (1);RNA recognition motif domain (3);	0.000000	0.85682	D	0.000000	T	0.80248	0.4588	N	0.16368	0.405	0.80722	D	1	P	0.46987	0.888	P	0.50231	0.635	T	0.77672	-0.2500	10	0.19147	T	0.46	-19.2949	13.9741	0.64259	0.0:0.0:0.0:1.0	.	162	Q9NW13	RBM28_HUMAN	R	162;196	ENSP00000223073:K162R;ENSP00000420503:K196R	ENSP00000223073:K162R	K	-	2	0	RBM28	127765596	1.000000	0.71417	1.000000	0.80357	0.999000	0.98932	4.911000	0.63328	2.190000	0.69967	0.528000	0.53228	AAA	RBM28-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000349442.1	66.599648	KEEP		-	68.957598	0.310811	23	51	---	---	---	---	1	0.9895302	9	12	0	74	27	65	0	74	2	1	1	51	156	1	243	27	65	0	74	8	TP
RBM33	155435	broad.mit.edu	37	7	155534608	155534608	+	Silent	SNP	G	G	A			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr7:155534608G>A	ENST00000401878.3	+	13	2343	c.2145G>A	c.(2143-2145)ccG>ccA	p.P715P		NM_053043.2	NP_444271.2	Q96EV2	RBM33_HUMAN	RNA binding motif protein 33	715		NA					nucleotide binding|RNA binding			breast(3)|cervix(1)|endometrium(8)|kidney(3)|large_intestine(4)|lung(6)|ovary(1)|upper_aerodigestive_tract(1)	27	all_neural(206;0.101)	all_hematologic(28;0.0592)	OV - Ovarian serous cystadenocarcinoma(82;0.011)	UCEC - Uterine corpus endometrioid carcinoma (81;0.2)		CCATAGCGCCGTCACACGTGA	0.562	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						97	96	96	NA		NA	NA	7		NA											NA				155534608		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000184863	HGNC:27223	NM_001008408	Approved	uc010lqk.1	NA	A4D244|B5MC24|Q52LF5|Q75LN9|Q75ML5|Q9NSV0	ENST00000401878.3	37	CCDS5941.2	.	.	.	.	.	.	.	.	.	.	G	0.194	-1.051068	0.01981	.	.	ENSG00000184863	ENST00000392761	.	.	.	5.88	-11.8	0.00035	.	.	.	.	.	T	0.32164	0.0820	.	.	.	0.80722	D	1	.	.	.	.	.	.	T	0.50972	-0.8764	4	.	.	.	.	2.4898	0.04607	0.182:0.1248:0.4411:0.2521	.	.	.	.	H	487	.	.	R	+	2	0	RBM33	155227369	0.000000	0.05858	0.000000	0.03702	0.009000	0.06853	-2.326000	0.01114	-4.050000	0.00078	-2.432000	0.00214	CGT	RBM33-007	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000317225.3	31.452026	KEEP		+	38.748012	0.202247	18	71	---	---	---	---	1	0.9882538	21	17	1	101	22	78	1	101	3	0	0	0	0	0	0	22	78	1	101	2	TP
NEIL2	252969	broad.mit.edu	37	8	11643642	11643642	+	Nonsense_Mutation	SNP	C	C	T			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr8:11643642C>T	ENST00000284503.6	+	5	1458	c.859C>T	c.(859-861)Cag>Tag	p.Q287*	NEIL2_ENST00000436750.3_Nonsense_Mutation_p.Q287*|NEIL2_ENST00000403422.3_Nonsense_Mutation_p.Q226*|NEIL2_ENST00000455213.2_Nonsense_Mutation_p.Q287*|NEIL2_ENST00000528323.1_Nonsense_Mutation_p.Q171*	NM_145043.2	NP_659480.1	Q969S2	NEIL2_HUMAN	nei endonuclease VIII-like 2 (E. coli)	287		NA			base-excision repair|nucleotide-excision repair	nucleus	damaged DNA binding|DNA-(apurinic or apyrimidinic site) lyase activity|hydrolase activity, hydrolyzing N-glycosyl compounds|zinc ion binding			endometrium(1)|kidney(1)|large_intestine(3)|lung(4)|upper_aerodigestive_tract(1)	10	all_epithelial(15;0.103)		STAD - Stomach adenocarcinoma(15;0.00225)	COAD - Colon adenocarcinoma(149;0.166)		ACAGGTCTACCAGAAAGAACA	0.622	NA	NA					NA	Base excision repair (BER), DNA glycosylases						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						52	48	49	NA		NA	NA	8		NA											NA				11643642		2203	4300	6503	SO:0001587	stop_gained			ENSG00000154328	HGNC:18956	NM_145043	Approved	uc003wue.2	NA	Q7Z3Q7|Q8N842|Q8NG52	ENST00000284503.6	37	CCDS5984.1	.	.	.	.	.	.	.	.	.	.	C	23.8	4.456696	0.84317	.	.	ENSG00000154328	ENST00000455213;ENST00000403422;ENST00000528323;ENST00000436750;ENST00000284503;ENST00000382309	.	.	.	5.34	5.34	0.76211	.	0.164099	0.53938	D	0.000057	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	0.06891	T	0.86	-14.7392	13.3876	0.60805	0.1572:0.8428:0.0:0.0	.	.	.	.	X	287;226;171;287;287;272	.	ENSP00000284503:Q287X	Q	+	1	0	NEIL2	11681051	1.000000	0.71417	1.000000	0.80357	0.244000	0.25665	1.553000	0.36255	2.653000	0.90120	0.655000	0.94253	CAG	NEIL2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000207583.3	-9.861445	KEEP		+	46.003516	0.080386	25	286	---	---	---	---	1	1	35	402	0	52	26	300	0	52	2	0	0	0	0	0	0	26	300	0	52	2	TP
FDFT1	2222	broad.mit.edu	37	8	11687890	11687890	+	Silent	SNP	C	C	G			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr8:11687890C>G	ENST00000220584.4	+	6	1062	c.840C>G	c.(838-840)ctC>ctG	p.L280L	FDFT1_ENST00000538689.1_Silent_p.L169L|FDFT1_ENST00000528812.1_Silent_p.L216L|FDFT1_ENST00000530664.1_Silent_p.L216L|FDFT1_ENST00000528643.1_Silent_p.L195L|FDFT1_ENST00000443614.2_Silent_p.L237L|FDFT1_ENST00000525777.1_Silent_p.L195L|FDFT1_ENST00000446331.2_3'UTR|FDFT1_ENST00000525900.1_Silent_p.L273L	NM_004462.3	NP_004453.3	P37268	FDFT_HUMAN	farnesyl-diphosphate farnesyltransferase 1	280		NA			cholesterol biosynthetic process|isoprenoid biosynthetic process	endoplasmic reticulum membrane|integral to membrane	farnesyl-diphosphate farnesyltransferase activity|oxidoreductase activity|protein binding|squalene synthase activity			breast(1)|endometrium(1)|large_intestine(3)|lung(2)|prostate(1)|stomach(2)|upper_aerodigestive_tract(2)	12	all_epithelial(15;0.234)		STAD - Stomach adenocarcinoma(15;0.00225)	COAD - Colon adenocarcinoma(149;0.18)		TTTCGAGACTCAGAAACCAGA	0.512	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						171	148	156	NA		NA	NA	8		NA											NA				11687890		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000079459	HGNC:3629		Approved	uc003wui.3	NA	Q96GT0	ENST00000220584.4	37	CCDS5985.1																																																																																			FDFT1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000207588.2	-184.227652	KEEP		+	6.703462	0.007386	5	672	---	---	---	---	1	0.9998747	9	3035	0	173	6	812	0	173	2	0	0	0	0	0	0	6	812	0	173	2	TP
BRF2	55290	broad.mit.edu	37	8	37702081	37702081	+	Missense_Mutation	SNP	G	G	A			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr8:37702081G>A	ENST00000220659.6	-	4	1307	c.1187C>T	c.(1186-1188)cCt>cTt	p.P396L	GPR124_ENST00000315215.7_3'UTR	NM_018310.3	NP_060780.2	Q9HAW0	BRF2_HUMAN	BRF2, RNA polymerase III transcription initiation factor 50 kDa subunit	396		NA			regulation of transcription, DNA-dependent|transcription from RNA polymerase III promoter|transcription initiation, DNA-dependent	nucleoplasm	protein binding|zinc ion binding			breast(1)|endometrium(1)|large_intestine(3)|liver(1)|lung(5)|ovary(1)	12		Lung NSC(58;0.118)|all_lung(54;0.195)	BRCA - Breast invasive adenocarcinoma(5;2.75e-24)|LUSC - Lung squamous cell carcinoma(8;1.81e-10)			AACTTCCTGAGGGGTACGCAA	0.527	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						67	73	71	NA		NA	NA	8		NA											NA				37702081		2203	4300	6503	SO:0001583	missense			ENSG00000104221	HGNC:17298	NM_018310	Approved	uc003xkk.3	NA	B2RD62|D3DSW6|Q9H2Y3|Q9H3B3|Q9NUY6	ENST00000220659.6	37	CCDS6098.1	.	.	.	.	.	.	.	.	.	.	G	21.7	4.181662	0.78677	.	.	ENSG00000104221	ENST00000220659;ENST00000545765	.	.	.	5.28	4.35	0.52113	.	0.260216	0.38778	N	0.001580	T	0.67804	0.2932	M	0.61703	1.905	0.80722	D	1	D	0.67145	0.996	P	0.58970	0.849	T	0.67162	-0.5740	9	0.37606	T	0.19	.	14.3111	0.66416	0.0:0.0:0.8508:0.1492	.	396	Q9HAW0	BRF2_HUMAN	L	396;373	.	ENSP00000220659:P396L	P	-	2	0	BRF2	37821239	1.000000	0.71417	0.997000	0.53966	0.995000	0.86356	4.222000	0.58580	2.451000	0.82905	0.561000	0.74099	CCT	BRF2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000376811.2	1.408287	KEEP		-	6.968072	0.090909	3	30	---	---	---	---	1	0.9811536	17	83	0	47	3	33	0	47	2	0	0	0	0	0	0	3	33	0	47	2	TP
ZNF704	619279	broad.mit.edu	37	8	81553643	81553643	+	Silent	SNP	G	G	A			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr8:81553643G>A	ENST00000327835.3	-	9	1428	c.1197C>T	c.(1195-1197)acC>acT	p.T399T		NM_001033723.2	NP_001028895.1	Q6ZNC4	ZN704_HUMAN	zinc finger protein 704	399		NA				intracellular	zinc ion binding			lung(9)|skin(1)|upper_aerodigestive_tract(1)	11	all_cancers(3;8.53e-08)|all_epithelial(4;4.59e-10)|Breast(3;2.56e-06)|Lung NSC(7;2.58e-06)|all_lung(9;9.4e-06)		BRCA - Breast invasive adenocarcinoma(6;0.00401)|Epithelial(68;0.00448)|all cancers(69;0.0277)			AGCGGCAGGCGGTACACCACA	0.612	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						70	56	61	NA		NA	NA	8		NA											NA				81553643		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000164684	HGNC:32291	NM_001033723	Approved	uc003yby.2	NA	B2RNE6|B9EGW6	ENST00000327835.3	37	CCDS34913.1																																																																																			ZNF704-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000379964.2	4.716853	KEEP		-	8.601725	0.133333	4	26	---	---	---	---	1	0.8296425	5	18	0	30	6	38	0	30	2	0	0	0	0	0	0	6	38	0	30	2	TP
DCAF13	25879	broad.mit.edu	37	8	104452417	104452417	+	Missense_Mutation	SNP	C	C	T			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr8:104452417C>T	ENST00000297579.5	+	9	1737	c.1460C>T	c.(1459-1461)tCt>tTt	p.S487F	DCAF13_ENST00000521999.1_3'UTR	NM_015420.6	NP_056235.4	Q9NV06	DCA13_HUMAN	DDB1 and CUL4 associated factor 13	335		NA			rRNA processing	CUL4 RING ubiquitin ligase complex|nucleolus|ribonucleoprotein complex				NS(1)|breast(1)|kidney(2)|large_intestine(8)|lung(8)|prostate(2)|skin(2)|upper_aerodigestive_tract(1)	25						AAATGGACTTCTGACAGCAAG	0.348	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						170	173	172	NA		NA	NA	8		NA											NA				104452417		2203	4300	6503	SO:0001583	missense			ENSG00000164934	HGNC:24535	NM_015420	Approved	uc003yln.3	NA	Q3MII9|Q8NCH8|Q8TC51|Q96JY7|Q9NZX3	ENST00000297579.5	37	CCDS34934.1	.	.	.	.	.	.	.	.	.	.	C	11.29	1.595034	0.28445	.	.	ENSG00000164934	ENST00000297579	T	0.60672	0.17	5.01	5.01	0.66863	WD40/YVTN repeat-like-containing domain (1);WD40 repeat-like-containing domain (1);WD40-repeat-containing domain (1);	0.333784	0.30800	N	0.008844	T	0.54515	0.1863	L	0.54323	1.7	0.80722	D	1	B	0.21147	0.052	B	0.28784	0.094	T	0.51371	-0.8714	10	0.10111	T	0.7	-13.8009	18.5005	0.90879	0.0:1.0:0.0:0.0	.	335	Q9NV06	DCA13_HUMAN	F	487	ENSP00000297579:S487F	ENSP00000297579:S487F	S	+	2	0	DCAF13	104521593	0.988000	0.35896	0.998000	0.56505	0.984000	0.73092	4.477000	0.60223	2.587000	0.87381	0.655000	0.94253	TCT	DCAF13-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000380797.2	-7.674498	KEEP		+	20.986716	0.067568	10	138	---	---	---	---	1	0.9999992	67	402	0	130	11	156	0	130	2	0	0	0	0	0	0	11	156	0	130	2	TP
DCAF12	25853	broad.mit.edu	37	9	34089583	34089583	+	Missense_Mutation	SNP	G	G	A			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr9:34089583G>A	ENST00000361264.4	-	8	1371	c.1030C>T	c.(1030-1032)Cgg>Tgg	p.R344W	RP11-537H15.3_ENST00000448245.1_RNA	NM_015397.3	NP_056212.1	Q5T6F0	DCA12_HUMAN	DDB1 and CUL4 associated factor 12	344		NA				centrosome|CUL4 RING ubiquitin ligase complex				breast(1)|endometrium(2)|kidney(1)|large_intestine(2)|lung(4)|prostate(1)	11						CTCACTGACCGGATTCCTGAA	0.488	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						50	46	48	NA		NA	NA	9		NA											NA				34089583		2203	4300	6503	SO:0001583	missense			ENSG00000198876	HGNC:19911	NM_015397	Approved	uc003ztt.2	NA	A8KA70|D3DRL6|Q5T6E9|Q5T6F1|Q6P3V0|Q7L4F8|Q96PZ5|Q9NXA9|Q9UFJ1	ENST00000361264.4	37	CCDS6549.1	.	.	.	.	.	.	.	.	.	.	G	26.1	4.701129	0.88924	.	.	ENSG00000198876	ENST00000361264	T	0.63913	-0.07	5.21	5.21	0.72293	WD40/YVTN repeat-like-containing domain (1);WD40 repeat-like-containing domain (1);	0.000000	0.85682	D	0.000000	T	0.80829	0.4698	M	0.82517	2.595	0.80722	D	1	D	0.89917	1.0	D	0.74348	0.983	T	0.81846	-0.0745	10	0.45353	T	0.12	-19.657	18.3346	0.90283	0.0:0.0:1.0:0.0	.	344	Q5T6F0	DCA12_HUMAN	W	344	ENSP00000355114:R344W	ENSP00000355114:R344W	R	-	1	2	DCAF12	34079583	1.000000	0.71417	1.000000	0.80357	0.811000	0.45836	7.092000	0.76930	2.436000	0.82500	0.655000	0.94253	CGG	DCAF12-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000052133.2	9.491253	KEEP		-	15.518384	0.142857	7	42	---	---	---	---	1	0.9999758	37	106	0	50	9	50	0	50	2	0	0	0	0	0	0	9	50	0	50	2	TP
ZNF248	57209	broad.mit.edu	37	10	38121178	38121178	+	Missense_Mutation	SNP	G	G	T	rs137877519		STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr10:38121178G>T	ENST00000395867.3	-	6	1655	c.1105C>A	c.(1105-1107)Cag>Aag	p.Q369K	ZNF248_ENST00000357328.4_Missense_Mutation_p.Q369K|ZNF248_ENST00000494133.1_Intron|AL135791.1_ENST00000583461.1_RNA|ZNF248_ENST00000374648.3_Intron	NM_001267605.1|NM_001267606.1|NM_001267607.1|NM_021045.2	NP_001254534.1|NP_001254535.1|NP_001254536.1|NP_066383.1	Q8NDW4	ZN248_HUMAN	zinc finger protein 248	369		NA			regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding			NS(1)|endometrium(2)|large_intestine(5)|lung(9)|ovary(2)|urinary_tract(1)	20						CTCCGAAGCTGGGTAAGATGT	0.408	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						102	98	99	NA		NA	NA	10		NA											NA				38121178		2203	4299	6502	SO:0001583	missense			ENSG00000198105	HGNC:13041	NM_021045	Approved	uc010qeu.2	NA	Q9UMP3	ENST00000395867.3	37	CCDS7194.1	.	.	.	.	.	.	.	.	.	.	G	4.100	0.016601	0.07959	.	.	ENSG00000198105	ENST00000395867;ENST00000357328	T;T	0.14640	2.49;2.49	4.6	3.62	0.41486	Zinc finger, C2H2-type/integrase, DNA-binding (1);	0.144833	0.32444	N	0.006082	T	0.09468	0.0233	L	0.33710	1.025	0.21064	N	0.999794	B	0.18863	0.031	B	0.11329	0.006	T	0.28870	-1.0030	10	0.08381	T	0.77	.	12.5906	0.56441	0.0:0.1691:0.8309:0.0	.	369	Q8NDW4	ZN248_HUMAN	K	369	ENSP00000379208:Q369K;ENSP00000349882:Q369K	ENSP00000349882:Q369K	Q	-	1	0	ZNF248	38161184	0.000000	0.05858	0.999000	0.59377	0.671000	0.39405	0.107000	0.15375	2.550000	0.86006	0.557000	0.71058	CAG	ZNF248-004	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000047609.1	-12.484134	KEEP		-	18.088533	0.064516	10	145	---	---	---	---	1	0.4876325	13	11	0	140	11	161	0	140	2	0	0	0	0	0	0	11	161	0	140	2	TP
CNNM2	54805	broad.mit.edu	37	10	104679833	104679833	+	Silent	SNP	C	C	T			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr10:104679833C>T	ENST00000369878.3	+	1	1720	c.1596C>T	c.(1594-1596)gaC>gaT	p.D532D	CNNM2_ENST00000369875.3_Silent_p.D532D|CNNM2_ENST00000457502.2_Silent_p.D290D|CNNM2_ENST00000433628.2_Silent_p.D532D	NM_017649.4	NP_060119.3	Q9H8M5	CNNM2_HUMAN	cyclin M2	532	CBS 2.	NA			ion transport	integral to membrane				central_nervous_system(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(5)|lung(7)|ovary(1)|prostate(2)|urinary_tract(1)	19		Colorectal(252;0.103)|all_hematologic(284;0.152)|Breast(234;0.198)		Epithelial(162;7.89e-09)|all cancers(201;1.82e-07)|BRCA - Breast invasive adenocarcinoma(275;0.215)		CCAAGTTGGACGCTATGCTGG	0.458	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						117	123	121	NA		NA	NA	10		NA											NA				104679833		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000148842	HGNC:103	NM_017649	Approved	uc001kwm.3	NA	Q5T569|Q5T570|Q8WU59|Q9H952|Q9NRK5|Q9NXT4	ENST00000369878.3	37	CCDS44474.1																																																																																			CNNM2-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		22.320103	KEEP		+	45.667253	0.130682	23	153	---	---	---	---	1	0.9983899	12	53	0	149	29	180	0	149	2	0	0	0	0	0	0	29	180	0	149	2	TP
SLK	9748	broad.mit.edu	37	10	105750529	105750529	+	Silent	SNP	T	T	C			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr10:105750529T>C	ENST00000369755.3	+	2	792	c.247T>C	c.(247-249)Tta>Cta	p.L83L	SLK_ENST00000335753.4_Silent_p.L83L	NM_014720.2	NP_055535.2	Q9H2G2	SLK_HUMAN	STE20-like kinase	83	Protein kinase.	NA			apoptosis|nucleotide-excision repair	cytoplasm|plasma membrane	ATP binding|DNA binding|nuclease activity|protein serine/threonine kinase activity			kidney(1)|lung(1)|ovary(2)|skin(2)|stomach(2)	8		Colorectal(252;0.178)		Epithelial(162;5.81e-10)|all cancers(201;2.35e-08)|BRCA - Breast invasive adenocarcinoma(275;0.0165)		GATTGACATATTAGCATCTTG	0.368	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NSCLC(111;540 1651 1927 4474 17706)					NA		NA		NA		0			NA	NA	NA	NA	NA						130	122	125	NA		NA	NA	10		NA											NA				105750529		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000065613	HGNC:11088	NM_014720	Approved	uc001kxo.1	NA	D3DRA0|D3DRA1|O00211|Q6P1Z4|Q86WU7|Q86WW1|Q92603|Q9NQL0|Q9NQL1	ENST00000369755.3	37	CCDS7553.1																																																																																			SLK-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000050188.1	40.170535	KEEP		+	43.72918	0.253968	16	47	---	---	---	---	1	1	28	138	0	66	16	53	0	66	2	0	0	0	0	0	0	16	53	0	66	2	TP
PPP2R2D	55844	broad.mit.edu	37	10	133761176	133761176	+	Splice_Site	SNP	G	G	A			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr10:133761176G>A	ENST00000422256.2	+	6	764		c.e6+1		PPP2R2D_ENST00000470416.1_3'UTR			Q66LE6	2ABD_HUMAN	protein phosphatase 2, regulatory subunit B, delta	NA		NA			cell division|exit from mitosis|mitosis|signal transduction	cytoplasm|protein phosphatase type 2A complex	protein phosphatase type 2A regulator activity			endometrium(3)|large_intestine(3)|liver(1)|lung(4)|skin(1)|upper_aerodigestive_tract(1)	13		all_cancers(35;2.16e-12)|all_epithelial(44;2.77e-09)|Lung NSC(174;0.00237)|all_lung(145;0.00354)|Colorectal(31;0.0124)|Breast(234;0.023)|all_neural(114;0.0299)|Melanoma(40;0.123)|Glioma(114;0.203)		OV - Ovarian serous cystadenocarcinoma(35;7.86e-05)|Epithelial(32;8.82e-05)|all cancers(32;0.000106)|BRCA - Breast invasive adenocarcinoma(275;0.21)		ACCTCAACATGGAGAGCAGGC	0.498	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						77	79	79	NA		NA	NA	10		NA											NA				133761176		2032	4209	6241	SO:0001630	splice_region_variant			ENSG00000175470	HGNC:23732	NM_018461	Approved	uc001lks.3	NA	A8KAK0|Q5SQJ2|Q9P1Y7	ENST00000422256.2	37		.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	G|G	17.12|17.12	3.307598|3.307598	0.60305|0.60305	.|.	.|.	ENSG00000175470|ENSG00000175470	ENST00000422256|ENST00000455566	.|T	.|0.28454	.|1.61	2.98|2.98	2.07|2.07	0.26955|0.26955	.|WD40/YVTN repeat-like-containing domain (1);WD40 repeat-like-containing domain (1);	.|0.041576	.|0.85682	.|D	.|0.000000	.|T	.|0.26919	.|0.0659	.|.	.|.	.|.	0.80722|0.80722	D|D	1|1	.|P	.|0.34815	.|0.47	.|B	.|0.35770	.|0.21	.|T	.|0.14924	.|-1.0455	.|9	.|0.87932	.|D	.|0	.|-19.0209	10.468|10.468	0.44620|0.44620	0.1018:0.0:0.8982:0.0|0.1018:0.0:0.8982:0.0	.|.	.|321	.|Q66LE6	.|2ABD_HUMAN	.|I	-1|290	.|ENSP00000399970:M290I	.|ENSP00000399970:M290I	.|M	+|+	.|3	.|0	PPP2R2D|PPP2R2D	133611166|133611166	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.955000|0.955000	0.61496|0.61496	6.897000|6.897000	0.75671|0.75671	0.828000|0.828000	0.34709|0.34709	0.655000|0.655000	0.94253|0.94253	.|ATG	PPP2R2D-201	KNOWN	basic	protein_coding	NA	protein_coding		6.749789	KEEP	Intron	+	17.26891	0.112676	8	63	---	---	---	---	1	0.9998324	19	136	0	63	9	75	0	63	2	0	0	0	0	0	0	9	75	0	63	2	TP
SIRT3	23410	broad.mit.edu	37	11	216681	216681	+	3'UTR	SNP	T	T	C			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr11:216681T>C	ENST00000382743.4	-	0	1319				SIRT3_ENST00000529382.1_3'UTR|SIRT3_ENST00000525319.1_3'UTR|SIRT3_ENST00000524564.1_3'UTR|SIRT3_ENST00000532956.1_3'UTR	NM_001017524.2|NM_012239.5	NP_001017524.1|NP_036371.1	Q9NTG7	SIRT3_HUMAN	sirtuin 3	NA		NA			chromatin silencing|protein ADP-ribosylation|protein deacetylation	mitochondrial matrix	hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides|NAD+ ADP-ribosyltransferase activity|NAD+ binding|protein binding|zinc ion binding			endometrium(1)|lung(5)|urinary_tract(1)	7		all_cancers(49;1.58e-09)|all_epithelial(84;2.71e-06)|Breast(177;0.000162)|Ovarian(85;0.000626)|Medulloblastoma(188;0.0109)|all_neural(188;0.0299)|Lung NSC(207;0.0538)|all_lung(207;0.0713)		all cancers(45;3.66e-27)|Epithelial(43;2.02e-26)|OV - Ovarian serous cystadenocarcinoma(40;2.9e-21)|BRCA - Breast invasive adenocarcinoma(625;3.88e-05)|Lung(200;0.111)|LUSC - Lung squamous cell carcinoma(625;0.129)		ATTTATTGTGTGGGGGCAGCC	0.478	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						192	168	176	NA		NA	NA	11		NA											NA				216681		2203	4300	6503	SO:0001624	3_prime_UTR_variant			ENSG00000142082	HGNC:14931		Approved	uc001lok.4	NA	Q9Y6E8	ENST00000382743.4	37	CCDS7691.1																																																																																			SIRT3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000239288.3	-1.233004	KEEP		-	12.901038	0.095238	8	76	---	---	---	---	1	0.9810509	4	55	0	107	11	91	0	107	2	0	0	0	0	0	0	11	91	0	107	2	TP
CD44	960	broad.mit.edu	37	11	35243229	35243229	+	Silent	SNP	G	G	A			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr11:35243229G>A	ENST00000263398.6	+	8	1265	c.831G>A	c.(829-831)ttG>ttA	p.L277L	CD44_ENST00000415148.2_Silent_p.L615L|CD44_ENST00000360158.4_Silent_p.L312L|CD44_ENST00000352818.4_Silent_p.L256L|CD44_ENST00000434472.2_Silent_p.L345L|CD44_ENST00000428726.2_Silent_p.L658L|CD44_ENST00000433354.2_Silent_p.L630L|CD44_ENST00000433892.2_Silent_p.L409L|CD44_ENST00000278386.6_Intron|CD44_ENST00000437706.2_Silent_p.L590L|CD44_ENST00000526669.2_Silent_p.L122L|CD44_ENST00000449691.2_Silent_p.L615L	NM_001001391.1|NM_001202555.1|NM_001202556.1	NP_001001391.1|NP_001189484.1|NP_001189485.1	P16070	CD44_HUMAN	CD44 molecule (Indian blood group)	658	Stem.	NA			cell-cell adhesion|cell-matrix adhesion|interferon-gamma-mediated signaling pathway|negative regulation of apoptosis|negative regulation of DNA damage response, signal transduction by p53 class mediator|positive regulation of ERK1 and ERK2 cascade|positive regulation of peptidyl-serine phosphorylation|positive regulation of peptidyl-tyrosine phosphorylation	cell surface|Golgi apparatus|integral to plasma membrane	collagen binding|hyaluronic acid binding|receptor activity			cervix(1)|endometrium(1)|kidney(2)|large_intestine(4)|lung(13)|pancreas(1)|skin(1)	23	all_cancers(35;0.212)|all_lung(20;0.0874)|all_epithelial(35;0.112)	all_hematologic(20;0.107)	STAD - Stomach adenocarcinoma(6;0.00731)		Hyaluronidase(DB00070)	CATCCCTCTTGGCCTTGGCTT	0.428	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						184	178	180	NA		NA	NA	11		NA											NA				35243229		2202	4298	6500	SO:0001819	synonymous_variant			ENSG00000026508	HGNC:1681	NM_000610	Approved	uc001mvu.3	NA	A5YRN9|D3DR12|D3DR13|P22511|Q04858|Q13419|Q13957|Q13958|Q13959|Q13960|Q13961|Q13967|Q13968|Q13980|Q15861|Q16064|Q16065|Q16066|Q16208|Q16522|Q86T72|Q86Z27|Q8N694|Q92493|Q96J24|Q9H5A5|Q9UC28|Q9UC29|Q9UC30|Q9UCB0|Q9UJ36	ENST00000263398.6	37	CCDS31457.1	.	.	.	.	.	.	.	.	.	.	G	9.823	1.186395	0.21870	.	.	ENSG00000026508	ENST00000442151	.	.	.	5.85	4.94	0.65067	.	.	.	.	.	T	0.70684	0.3252	.	.	.	0.80722	D	1	.	.	.	.	.	.	T	0.70107	-0.4963	4	.	.	.	-10.1836	14.8229	0.70087	0.0:0.0:0.8561:0.1439	.	.	.	.	S	277	.	.	G	+	1	0	CD44	35199805	1.000000	0.71417	1.000000	0.80357	0.994000	0.84299	5.944000	0.70219	1.469000	0.48083	0.561000	0.74099	GGC	CD44-003	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000388924.1	-7.372396	KEEP		+	14.89327	0.068966	8	108	---	---	---	---	1	1	335	1427	0	159	10	135	0	159	2	0	0	0	0	0	0	10	135	0	159	2	TP
C2CD3	26005	broad.mit.edu	37	11	73789208	73789208	+	Missense_Mutation	SNP	C	C	T			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr11:73789208C>T	ENST00000334126.7	-	23	4781	c.4555G>A	c.(4555-4557)Gac>Aac	p.D1519N	C2CD3_ENST00000313663.7_Missense_Mutation_p.D1519N			Q4AC94	C2CD3_HUMAN	C2 calcium-dependent domain containing 3	1519		NA				centrosome				NS(1)|breast(1)|cervix(1)|endometrium(2)|haematopoietic_and_lymphoid_tissue(1)|kidney(6)|large_intestine(16)|lung(26)|ovary(4)|pancreas(2)|prostate(1)|skin(3)	64	Breast(11;4.16e-06)					CTGGCCAGGTCCACATAGGCT	0.547	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						137	116	123	NA		NA	NA	11		NA											NA				73789208		2200	4293	6493	SO:0001583	missense			ENSG00000168014	HGNC:24564	NM_015531	Approved	uc001ouu.2	NA	C9JR55|E2QRD1|Q2NLE1|Q3C1U9|Q6ZU92|Q8IYM4|Q8NB87|Q8NDH7|Q9Y4M2	ENST00000334126.7	37		.	.	.	.	.	.	.	.	.	.	C	34	5.365755	0.95900	.	.	ENSG00000168014	ENST00000334126;ENST00000313663;ENST00000313681;ENST00000414160	D;D;D	0.87256	-2.23;-2.23;-2.23	5.35	5.35	0.76521	.	0.000000	0.85682	D	0.000000	D	0.93180	0.7828	M	0.71581	2.175	0.49051	D	0.999745	D	0.89917	1.0	D	0.87578	0.998	D	0.93645	0.6968	10	0.72032	D	0.01	-14.3665	18.6689	0.91502	0.0:1.0:0.0:0.0	.	1519	Q4AC94-1	.	N	1519;1519;1500;327	ENSP00000334379:D1519N;ENSP00000323339:D1519N;ENSP00000388750:D327N	ENSP00000323339:D1519N	D	-	1	0	C2CD3	73466856	1.000000	0.71417	1.000000	0.80357	0.989000	0.77384	7.474000	0.81024	2.502000	0.84385	0.650000	0.86243	GAC	C2CD3-201	KNOWN	basic	protein_coding	NA	protein_coding		-6.639993	KEEP		-	12.708444	0.069307	7	94	---	---	---	---	1	0.7430128	5	33	0	105	8	111	0	105	2	0	0	0	0	0	0	8	111	0	105	2	TP
SCFD1	23256	broad.mit.edu	37	14	31191756	31191756	+	Silent	SNP	C	C	T			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr14:31191756C>T	ENST00000458591.2	+	23	2054	c.1827C>T	c.(1825-1827)gaC>gaT	p.D609D	SCFD1_ENST00000541123.1_Silent_p.D424D|SCFD1_ENST00000544052.2_Silent_p.D542D|SCFD1_ENST00000421551.3_Silent_p.D550D|SCFD1_ENST00000396629.2_Silent_p.D517D	NM_016106.3	NP_057190.2	Q8WVM8	SCFD1_HUMAN	sec1 family domain containing 1	609		NA			post-Golgi vesicle-mediated transport|protein transport|regulation of ER to Golgi vesicle-mediated transport|response to toxin|retrograde vesicle-mediated transport, Golgi to ER|vesicle docking involved in exocytosis	cis-Golgi network|endoplasmic reticulum membrane|Golgi cisterna membrane|Golgi-associated vesicle|plasma membrane	syntaxin-5 binding			endometrium(2)|kidney(1)|large_intestine(4)|lung(5)|prostate(1)	13	Hepatocellular(127;0.0877)		LUAD - Lung adenocarcinoma(48;0.00192)|Lung(238;0.0119)	GBM - Glioblastoma multiforme(265;0.0181)		ATCTTGTTGACTACATAAAGG	0.328	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						158	151	153	NA		NA	NA	14		NA											NA				31191756		2203	4299	6502	SO:0001819	synonymous_variant			ENSG00000092108	HGNC:20726	NM_182835	Approved	uc001wqm.2	NA	A8K2Z5|O60754|O94990|Q7Z529|Q9BZI3|Q9UNL3|Q9Y6A8	ENST00000458591.2	37	CCDS9639.1																																																																																			SCFD1-006	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000276612.3	35.995053	KEEP		+	40.124987	0.234375	15	49	---	---	---	---	1	1	62	84	0	54	18	60	0	54	2	0	0	0	0	0	0	18	60	0	54	2	TP
Unknown	0	broad.mit.edu	37	14	106134543	106134543	+	IGR	SNP	G	G	C	rs3211547		STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr14:106134543G>C			NA	NA				RP11-731F5.2 (19149 upstream) : AL928768.3 (35757 downstream)						NA		NA									NA						TCGTGCGACCGCGAGAGCCCG	0.642	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA	SO:0001628	intergenic_variant								NA			37																																																																																								0			0.407991	KEEP			6.489503	0.085714	3	32	---	---	---	---	1	0.8912699	5826	1134	1	49	3	39	1	49	298	0	0	0	0	0	0	3	39	1	49	2	TP
SF3B3	23450	broad.mit.edu	37	16	70602310	70602310	+	Missense_Mutation	SNP	A	A	T			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr16:70602310A>T	ENST00000302516.5	+	22	3288	c.3077A>T	c.(3076-3078)gAt>gTt	p.D1026V		NM_012426.4	NP_036558.3	Q15393	SF3B3_HUMAN	splicing factor 3b, subunit 3, 130kDa	1026		NA			protein complex assembly	catalytic step 2 spliceosome|nucleoplasm|small nuclear ribonucleoprotein complex|U12-type spliceosomal complex	nucleic acid binding|protein binding			breast(2)|endometrium(8)|kidney(2)|large_intestine(8)|liver(3)|lung(21)|ovary(1)|prostate(1)|skin(2)|stomach(1)|upper_aerodigestive_tract(2)|urinary_tract(2)	53		Ovarian(137;0.0694)				ATCTTTGCTGATGATACCTAC	0.468	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						162	147	152	NA		NA	NA	16		NA											NA				70602310		2198	4300	6498	SO:0001583	missense			ENSG00000189091	HGNC:10770	NM_012426	Approved	uc002ezf.3	NA	Q6NTI8|Q96GC0|Q9BPY2|Q9UFX7|Q9UJ29	ENST00000302516.5	37	CCDS10894.1	.	.	.	.	.	.	.	.	.	.	A	30	5.055964	0.93793	.	.	ENSG00000189091	ENST00000302516	T	0.49139	0.79	5.92	5.92	0.95590	Cleavage/polyadenylation specificity factor, A subunit, C-terminal (1);	0.048057	0.85682	D	0.000000	T	0.77260	0.4104	M	0.93854	3.465	0.80722	D	1	D	0.89917	1.0	D	0.97110	1.0	D	0.83524	0.0087	10	0.72032	D	0.01	.	16.3526	0.83220	1.0:0.0:0.0:0.0	.	1026	Q15393	SF3B3_HUMAN	V	1026	ENSP00000305790:D1026V	ENSP00000305790:D1026V	D	+	2	0	SF3B3	69159811	1.000000	0.71417	1.000000	0.80357	0.984000	0.73092	9.157000	0.94714	2.255000	0.74692	0.533000	0.62120	GAT	SF3B3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000268972.1	-2.43785	KEEP		+	7.623341	0.074074	4	50	---	---	---	---	1	0.9999066	151	303	0	62	4	54	0	62	2	0	0	0	0	0	0	4	54	0	62	2	TP
NPIPB15	440348	broad.mit.edu	37	16	74425446	74425446	+	Missense_Mutation	SNP	C	C	T			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr16:74425446C>T	ENST00000429990.1	+	7	896	c.800C>T	c.(799-801)cCc>cTc	p.P267L						nuclear pore complex interacting protein family, member B15	NA		NA									NA						AAGACACCTCCCGAATGTCTC	0.493	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						126	124	125	NA		NA	NA	16		NA											NA				74425446		2180	4287	6467	SO:0001583	missense			ENSG00000196436	HGNC:34409	NM_001018059	Approved	uc010vmt.1	NA		ENST00000429990.1	37		.	.	.	.	.	.	.	.	.	.	c	4.380	0.070021	0.08436	.	.	ENSG00000196436	ENST00000504746;ENST00000429990	T	0.60797	0.16	.	.	.	.	.	.	.	.	T	0.46639	0.1403	L	0.50333	1.59	0.09310	N	1	B	0.12630	0.006	B	0.21360	0.034	T	0.37033	-0.9723	6	0.33940	T	0.23	.	.	.	.	.	206	A6NHN6	NPPL2_HUMAN	L	145;267	ENSP00000411140:P267L	ENSP00000411140:P267L	P	+	2	0	NPIPL2	72982947	.	.	.	.	.	.	.	.	.	.	.	.	CCC	NPIPB15-001	KNOWN	basic	protein_coding	NA	protein_coding	OTTHUMT00000346597.2	-5.353973	KEEP		+	21.672092	0.070423	10	132	---	---	---	---	1	0.2141804	4	8	0	146	11	154	0	146	2	0	0	0	0	0	0	11	154	0	146	2	TP
TM4SF5	9032	broad.mit.edu	37	17	4675218	4675218	+	Start_Codon_SNP	SNP	A	A	T			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr17:4675218A>T	ENST00000270560.3	+	1	32	c.1A>T	c.(1-3)Atg>Ttg	p.M1L		NM_003963.2	NP_003954.2	O14894	T4S5_HUMAN	transmembrane 4 L six family member 5	1		NA				integral to plasma membrane				large_intestine(2)|lung(3)|ovary(1)	6						ACACCTCACCATGTGTACGGG	0.567	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						201	175	184	NA		NA	NA	17		NA											NA				4675218		2203	4300	6503	SO:0001582	initiator_codon_variant			ENSG00000142484	HGNC:11857		Approved	uc002fyw.1	NA	Q17RW9|Q6IB79	ENST00000270560.3	37	CCDS11054.1	.	.	.	.	.	.	.	.	.	.	A	23.9	4.475646	0.84640	.	.	ENSG00000142484	ENST00000270560	T	0.32515	1.45	5.27	5.27	0.74061	.	0.141160	0.64402	D	0.000018	T	0.55893	0.1949	.	.	.	0.80722	D	1	P	0.52463	0.953	D	0.70716	0.97	T	0.60845	-0.7182	9	0.87932	D	0	-44.1366	13.1592	0.59535	1.0:0.0:0.0:0.0	.	1	O14894	T4S5_HUMAN	L	1	ENSP00000270560:M1L	ENSP00000270560:M1L	M	+	1	0	TM4SF5	4621967	1.000000	0.71417	0.957000	0.39632	0.673000	0.39480	6.690000	0.74567	1.990000	0.58119	0.533000	0.62120	ATG	TM4SF5-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000207558.2	12.443089	KEEP	Missense_Mutation	+	34.621706	0.104895	15	128	---	---	---	---	1	0.9999999	38	253	0	190	17	156	0	190	2	0	0	0	0	0	0	17	156	0	190	2	TP
TP53	7157	broad.mit.edu	37	17	7578208	7578208	+	Missense_Mutation	SNP	T	T	C			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr17:7578208T>C	ENST00000420246.2	-	6	773	c.641A>G	c.(640-642)cAt>cGt	p.H214R	TP53_ENST00000574684.1_Intron|TP53_ENST00000359597.4_Missense_Mutation_p.H214R|TP53_ENST00000455263.2_Missense_Mutation_p.H214R|TP53_ENST00000269305.4_Missense_Mutation_p.H214R|TP53_ENST00000445888.2_Missense_Mutation_p.H214R|TP53_ENST00000413465.2_Missense_Mutation_p.H214R	NM_001126114.2|NM_001276696.1	NP_001119586.1|NP_001263625.1	P04637	P53_HUMAN	tumor protein p53	214	Interaction with AXIN1 (By similarity).|Interaction with HIPK1 (By similarity).|Required for interaction with FBXO42.	NA	H -> D (in sporadic cancers; somatic mutation).|H -> P (in a sporadic cancer; somatic mutation).|H -> Q (in sporadic cancers; somatic mutation).|H -> R (in sporadic cancers; somatic mutation).|H -> Y (in sporadic cancers; somatic mutation).		activation of caspase activity by cytochrome c|base-excision repair|blood coagulation|cell cycle arrest|cell differentiation|cell proliferation|cellular protein localization|cellular response to drug|cellular response to glucose starvation|cellular response to hypoxia|cellular response to ionizing radiation|cellular response to UV|determination of adult lifespan|DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest|DNA damage response, signal transduction by p53 class mediator resulting in induction of apoptosis|DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator|ER overload response|interspecies interaction between organisms|negative regulation of apoptosis|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of helicase activity|negative regulation of transcription from RNA polymerase II promoter|nucleotide-excision repair|oxidative stress-induced premature senescence|positive regulation of histone deacetylation|positive regulation of neuron apoptosis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of reactive oxygen species metabolic process|positive regulation of thymocyte apoptosis|positive regulation of transcription from RNA polymerase II promoter|protein localization|protein tetramerization|Ras protein signal transduction|regulation of mitochondrial membrane permeability|replicative senescence|response to antibiotic|response to gamma radiation|response to X-ray	cytoplasm|cytosol|endoplasmic reticulum|insoluble fraction|mitochondrion|nuclear chromatin|nuclear matrix|nucleolus|nucleus|PML body|protein complex|replication fork	ATP binding|chaperone binding|chromatin binding|copper ion binding|damaged DNA binding|DNA strand annealing activity|histone acetyltransferase binding|p53 binding|protease binding|protein binding|protein heterodimerization activity|protein kinase binding|protein N-terminus binding|protein phosphatase 2A binding|RNA polymerase II transcription factor binding|sequence-specific DNA binding transcription factor activity|transcription regulatory region DNA binding|transcription repressor activity|ubiquitin protein ligase binding|zinc ion binding	p.H214R(61)|p.0?(8)|p.?(5)|p.H82R(4)|p.H214fs*33(4)|p.H121R(4)|p.H214fs*5(2)|p.D208fs*1(1)|p.H82fs*>9(1)|p.T211fs*28(1)|p.R213_S215>X(1)|p.D207_V216del10(1)|p.R213fs*32(1)|p.H121fs*33(1)|p.T211_S215delTFRHS(1)|p.R209fs*6(1)|p.D208_V216delDRNTFRHSV(1)		NS(16)|adrenal_gland(37)|autonomic_ganglia(16)|biliary_tract(273)|bone(108)|breast(2530)|central_nervous_system(1264)|cervix(68)|endometrium(223)|eye(24)|fallopian_tube(1)|gastrointestinal_tract_(site_indeterminate)(1)|genital_tract(16)|haematopoietic_and_lymphoid_tissue(1301)|kidney(96)|large_intestine(5124)|liver(897)|lung(2388)|meninges(5)|oesophagus(1473)|ovary(1659)|pancreas(452)|penis(10)|peritoneum(33)|pituitary(4)|placenta(1)|pleura(3)|prostate(235)|salivary_gland(43)|skin(791)|small_intestine(14)|soft_tissue(220)|stomach(1158)|testis(11)|thymus(21)|thyroid(54)|upper_aerodigestive_tract(2271)|urinary_tract(1259)|vagina(6)|vulva(79)	24185		all_cancers(10;1.01e-06)|Myeloproliferative disorder(207;0.0122)|Prostate(122;0.081)		GBM - Glioblastoma multiforme(2;1.59e-06)|READ - Rectum adenocarcinoma(115;0.174)		CACCACACTATGTCGAAAAGT	0.542	NA	111	"""Mis, N, F"""		"""breast, colorectal, lung, sarcoma, adrenocortical, glioma, multiple other tumour types"""	"""breast, sarcoma, adrenocortical carcinoma, glioma, multiple other tumour types"""	NA	Other conserved DNA damage response genes	Osteosarcoma, Familial Clustering of;Li-Fraumeni syndrome;Hereditary Breast-Ovarian Cancer, non-BRCA1/2;Hereditary Adrenocortical Cancer;Endometrial Cancer, Familial Clustering of	HNSCC(1;<9.43e-08)|TCGA GBM(1;<1E-08)|TSP Lung(2;<1E-08)|TCGA Ovarian(1;<1.89e-07)|Multiple Myeloma(5;0.019)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(47;798 1329 9957 10801)	yes	Rec	yes	Li-Fraumeni syndrome	17	17p13	7157	tumor protein p53	NA	"""L, E, M, O"""	98	Substitution - Missense(69)|Deletion - Frameshift(12)|Whole gene deletion(8)|Unknown(5)|Deletion - In frame(3)|Complex - deletion inframe(1)	lung(27)|liver(12)|ovary(8)|biliary_tract(6)|oesophagus(6)|upper_aerodigestive_tract(5)|central_nervous_system(5)|large_intestine(5)|urinary_tract(5)|prostate(4)|bone(4)|stomach(3)|breast(3)|haematopoietic_and_lymphoid_tissue(2)|soft_tissue(1)|skin(1)|pancreas(1)	NA	NA	NA	NA	NA						127	114	119	NA		NA	NA	17		NA											NA				7578208		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	Familial Osteogenic Sarcoma;LFS, SBLA syndrome (Sarcoma Breast Leukemia Adrenal cancer), incl.: Cancer with In Vitro Radioresistence, Familial, Li-Fraumeni-like s.;BRCAX;Familial Adrenocortical Carcinoma;	ENSG00000141510	HGNC:11998	NM_000546	Approved	uc002gij.3	NA	Q15086|Q15087|Q15088|Q16535|Q16807|Q16808|Q16809|Q16810|Q16811|Q16848|Q2XN98|Q3LRW1|Q3LRW2|Q3LRW3|Q3LRW4|Q3LRW5|Q86UG1|Q8J016|Q99659|Q9BTM4|Q9HAQ8|Q9NP68|Q9NPJ2|Q9NZD0|Q9UBI2|Q9UQ61	ENST00000420246.2	37	CCDS45606.1	.	.	.	.	.	.	.	.	.	.	T	35	5.548167	0.96488	.	.	ENSG00000141510	ENST00000413465;ENST00000359597;ENST00000269305;ENST00000455263;ENST00000420246;ENST00000445888;ENST00000396473;ENST00000545858;ENST00000509690;ENST00000514944;ENST00000414315	D;D;D;D;D;D;D;D	0.99755	-6.64;-6.64;-6.64;-6.64;-6.64;-6.64;-6.64;-6.64	5.28	5.28	0.74379	p53, DNA-binding domain (1);p53-like transcription factor, DNA-binding (1);p53/RUNT-type transcription factor, DNA-binding domain (1);	0.052737	0.85682	D	0.000000	D	0.99664	0.9875	M	0.75615	2.305	0.80722	D	1	D;D;P;D;D;D;D	0.76494	0.999;0.992;0.733;0.999;0.994;0.994;0.999	D;D;B;D;D;D;D	0.74674	0.984;0.947;0.376;0.982;0.95;0.968;0.962	D	0.97475	1.0043	10	0.72032	D	0.01	-26.1151	13.4753	0.61306	0.0:0.0:0.0:1.0	.	175;214;214;121;214;214;214	B4E095;P04637-2;P04637-3;E9PFT5;P04637;Q1MSW8;E7EQX7	.;.;.;.;P53_HUMAN;.;.	R	214;214;214;214;214;214;203;121;82;121;82	ENSP00000410739:H214R;ENSP00000352610:H214R;ENSP00000269305:H214R;ENSP00000398846:H214R;ENSP00000391127:H214R;ENSP00000391478:H214R;ENSP00000425104:H82R;ENSP00000423862:H121R	ENSP00000269305:H214R	H	-	2	0	TP53	7518933	1.000000	0.71417	0.283000	0.24790	0.961000	0.63080	7.996000	0.88334	2.128000	0.65567	0.460000	0.39030	CAT	TP53-005	KNOWN	NMD_exception|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000367401.1	27.779512	KEEP		-	30.161235	0.26087	12	34	---	---	---	---	1	1	198	65	0	50	14	41	0	50	2	1	1	97	174	1	264	14	41	0	50	6	TP
UBTF	7343	broad.mit.edu	37	17	42290195	42290195	+	Missense_Mutation	SNP	G	G	A			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr17:42290195G>A	ENST00000302904.4	-	7	1144	c.652C>T	c.(652-654)Cgg>Tgg	p.R218W	UBTF_ENST00000527034.1_Missense_Mutation_p.R218W|UBTF_ENST00000526094.1_Missense_Mutation_p.R218W|UBTF_ENST00000436088.1_Missense_Mutation_p.R218W|UBTF_ENST00000393606.3_Missense_Mutation_p.R218W|CTB-175E5.7_ENST00000586560.1_RNA|UBTF_ENST00000343638.5_Missense_Mutation_p.R218W|UBTF_ENST00000537550.1_5'Flank|UBTF_ENST00000529383.1_Missense_Mutation_p.R218W|UBTF_ENST00000533177.1_Missense_Mutation_p.R218W			P17480	UBF1_HUMAN	upstream binding transcription factor, RNA polymerase I	218		NA			positive regulation of transcription from RNA polymerase I promoter|termination of RNA polymerase I transcription|transcription elongation from RNA polymerase I promoter|transcription initiation from RNA polymerase I promoter	nucleolus|nucleoplasm	DNA binding|protein binding			breast(1)|central_nervous_system(2)|endometrium(1)|large_intestine(9)|lung(10)|ovary(1)|prostate(3)|upper_aerodigestive_tract(1)|urinary_tract(1)	29		Breast(137;0.00765)|Prostate(33;0.0181)		BRCA - Breast invasive adenocarcinoma(366;0.114)		ACATCTGGCCGCACTTTGAGA	0.637	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						169	148	155	NA		NA	NA	17		NA											NA				42290195		2203	4300	6503	SO:0001583	missense			ENSG00000108312	HGNC:12511	NM_014233	Approved	uc010czs.3	NA	A8K6R8	ENST00000302904.4	37	CCDS11480.1	.	.	.	.	.	.	.	.	.	.	g	24.1	4.489550	0.84962	.	.	ENSG00000108312	ENST00000343638;ENST00000302904;ENST00000527034;ENST00000533177;ENST00000436088;ENST00000393606;ENST00000526094;ENST00000529383	D;D;D;D;D;D;D;D	0.98493	-4.89;-4.65;-4.96;-4.89;-4.65;-4.89;-4.89;-4.65	4.83	4.83	0.62350	High mobility group, superfamily (1);High mobility group, HMG1/HMG2 (4);	0.212577	0.43260	D	0.000590	D	0.97145	0.9067	N	0.08118	0	0.51482	D	0.999925	D;D;D	0.89917	0.999;0.999;1.0	P;D;D	0.72625	0.895;0.928;0.978	D	0.98406	1.0570	10	0.59425	D	0.04	-26.9672	17.2714	0.87103	0.0:0.0:1.0:0.0	.	218;218;218	E9PKP7;P17480-2;P17480	.;.;UBF1_HUMAN	W	218	ENSP00000345297:R218W;ENSP00000302640:R218W;ENSP00000431539:R218W;ENSP00000437180:R218W;ENSP00000390669:R218W;ENSP00000377231:R218W;ENSP00000432925:R218W;ENSP00000435708:R218W	ENSP00000302640:R218W	R	-	1	2	UBTF	39645721	1.000000	0.71417	1.000000	0.80357	0.994000	0.84299	5.939000	0.70179	2.684000	0.91462	0.558000	0.71614	CGG	UBTF-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000395205.1	-19.04624	KEEP		-	6.868251	0.043103	5	111	---	---	---	---	1	0.9978719	17	272	0	129	6	134	0	129	2	0	0	0	0	0	0	6	134	0	129	2	TP
ZNF611	81856	broad.mit.edu	37	19	53208072	53208072	+	3'UTR	SNP	A	A	G			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr19:53208072A>G	ENST00000543227.1	-	0	2510				ZNF611_ENST00000453741.2_3'UTR|ZNF611_ENST00000595798.1_3'UTR|ZNF611_ENST00000540744.1_3'UTR|ZNF611_ENST00000602162.1_3'UTR|ZNF611_ENST00000319783.1_3'UTR	NM_001161499.1	NP_001154971.1	Q8N823	ZN611_HUMAN	zinc finger protein 611	NA		NA			regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding			breast(1)|endometrium(4)|kidney(4)|large_intestine(10)|lung(12)|ovary(1)|prostate(1)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(1)	36				OV - Ovarian serous cystadenocarcinoma(262;0.0233)|GBM - Glioblastoma multiforme(134;0.04)		TCCAGGTGTGAATCACTCCCA	0.403	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA	SO:0001624	3_prime_UTR_variant			ENSG00000213020	HGNC:28766	NM_030972	Approved	uc010ydq.2	NA	B3KRD5|Q69YG9	ENST00000543227.1	37	CCDS12855.1																																																																																			ZNF611-203	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		-3.068722	KEEP		-	11.243246	0.067568	5	69	---	---	---	---	1	0.3400573	3	11	0	92	6	73	0	92	2	0	0	0	0	0	0	6	73	0	92	2	TP
PYGB	5834	broad.mit.edu	37	20	25252030	25252030	+	Missense_Mutation	SNP	G	G	A			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr20:25252030G>A	ENST00000216962.4	+	4	546	c.436G>A	c.(436-438)Gac>Aac	p.D146N		NM_002862.3	NP_002853.2	P11216	PYGB_HUMAN	phosphorylase, glycogen; brain	146		NA			glucose metabolic process|glycogen catabolic process	cytoplasm	glycogen phosphorylase activity|pyridoxal phosphate binding			breast(1)|central_nervous_system(2)|cervix(1)|endometrium(5)|kidney(1)|large_intestine(4)|lung(12)|ovary(1)|skin(1)|stomach(1)|upper_aerodigestive_tract(2)	31					Pyridoxal Phosphate(DB00114)	GTGTTTCCTTGACTCAATGGC	0.502	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						232	213	220	NA		NA	NA	20		NA											NA				25252030		2203	4300	6503	SO:0001583	missense			ENSG00000100994	HGNC:9723	NM_002862	Approved	uc002wup.3	NA	Q96AK1|Q9NPX8	ENST00000216962.4	37	CCDS13171.1	.	.	.	.	.	.	.	.	.	.	G	25.6	4.650504	0.87958	.	.	ENSG00000100994	ENST00000216962	D	0.96200	-3.94	4.08	4.08	0.47627	.	0.095710	0.64402	D	0.000002	D	0.98729	0.9573	H	0.98721	4.31	0.80722	D	1	D	0.65815	0.995	D	0.78314	0.991	D	0.99421	1.0933	10	0.87932	D	0	-41.7248	16.4443	0.83913	0.0:0.0:1.0:0.0	.	146	P11216	PYGB_HUMAN	N	146	ENSP00000216962:D146N	ENSP00000216962:D146N	D	+	1	0	PYGB	25200030	1.000000	0.71417	1.000000	0.80357	0.754000	0.42855	9.492000	0.97957	2.256000	0.74724	0.563000	0.77884	GAC	PYGB-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000078415.2	52.83736	KEEP		+	59.226683	0.240385	25	79	---	---	---	---	1	1	175	417	0	121	39	133	0	121	2	0	0	0	0	0	0	39	133	0	121	2	TP
ADARB1	104	broad.mit.edu	37	21	46596225	46596225	+	Silent	SNP	C	C	T			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chr21:46596225C>T	ENST00000539173.1	+	4	1044	c.609C>T	c.(607-609)agC>agT	p.S203S	ADARB1_ENST00000437626.1_Intron|ADARB1_ENST00000360697.3_Silent_p.S203S|ADARB1_ENST00000389863.4_Silent_p.S203S|ADARB1_ENST00000348831.4_Silent_p.S203S	NM_015833.3	NP_056648.1	P78563	RED1_HUMAN	adenosine deaminase, RNA-specific, B1	203		NA			adenosine to inosine editing|mRNA modification|mRNA processing|RNA processing	nucleoplasm|nucleus	double-stranded RNA adenosine deaminase activity|double-stranded RNA binding|metal ion binding|mRNA binding|RNA binding			endometrium(4)|kidney(1)|large_intestine(3)|lung(8)|skin(1)	17				Colorectal(79;0.115)		TCAGTTCCAGCGGGGACCTCA	0.597	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						57	57	57	NA		NA	NA	21		NA											NA				46596225		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000197381	HGNC:226	NM_015833	Approved	uc002zgy.2	NA	A6NFK8|A6NJ84|C3TTQ1|O00395|O00465|O00691|O00692|P78555|Q4AE79|Q8NFD1	ENST00000539173.1	37	CCDS33589.1																																																																																			ADARB1-202	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		5.187929	KEEP		+	8.164649	0.153846	4	22	---	---	---	---	1	0.9846809	4	51	0	40	4	23	0	40	2	0	0	0	0	0	0	4	23	0	40	2	TP
PLXNA3	55558	broad.mit.edu	37	X	153698807	153698807	+	Missense_Mutation	SNP	A	A	C			STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	STAD-TCGA-BR-4255-Tumor-SM-1FRZ2	STAD-TCGA-BR-4255-Normal-SM-1FS2L	g.chrX:153698807A>C	ENST00000369682.3	+	30	5184	c.5009A>C	c.(5008-5010)gAt>gCt	p.D1670A	PLXNA3_ENST00000493546.1_3'UTR	NM_017514.3	NP_059984.2	P51805	PLXA3_HUMAN	plexin A3	1670		NA			axon guidance	integral to membrane|intracellular|plasma membrane	transmembrane receptor activity			breast(2)|central_nervous_system(2)|cervix(2)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(2)|lung(26)|ovary(2)|prostate(1)|upper_aerodigestive_tract(4)|urinary_tract(1)	48	all_cancers(53;5.05e-16)|all_epithelial(53;1.87e-10)|all_lung(58;1.84e-07)|Lung NSC(58;5.84e-07)|all_hematologic(71;2.45e-06)|Acute lymphoblastic leukemia(192;6.56e-05)|Breast(217;0.176)					AAGTTCGTGGATGACCTCTTT	0.607	NA	NA					NA							NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA							NA		NA		NA		0			NA	NA	NA	NA	NA						80	70	74	NA		NA	NA	X		NA											NA				153698807		2203	4300	6503	SO:0001583	missense			ENSG00000130827	HGNC:9101	NM_017514	Approved	uc004flm.3	NA	Q5HY36	ENST00000369682.3	37	CCDS14752.1	.	.	.	.	.	.	.	.	.	.	A	26.4	4.737302	0.89482	.	.	ENSG00000130827	ENST00000369682	T	0.17213	2.29	5.02	5.02	0.67125	Plexin, cytoplasmic RasGAP domain (1);Rho GTPase activation protein (1);	0.000000	0.85682	D	0.000000	T	0.48786	0.1519	M	0.91717	3.235	0.80722	D	1	D	0.64830	0.994	D	0.71414	0.973	T	0.60094	-0.7330	10	0.87932	D	0	.	12.8104	0.57637	1.0:0.0:0.0:0.0	.	1670	P51805	PLXA3_HUMAN	A	1670	ENSP00000358696:D1670A	ENSP00000358696:D1670A	D	+	2	0	PLXNA3	153352001	1.000000	0.71417	0.996000	0.52242	0.987000	0.75469	9.332000	0.96446	1.663000	0.50791	0.430000	0.28490	GAT	PLXNA3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000081634.1	-4.9819	KEEP		+	10.696912	0.063291	5	74	---	---	---	---	1	0.4744155	11	26	1	115	6	90	1	115	3	0	0	0	0	0	0	6	90	1	115	2	TP
